Clinical Trials Browser

Unknown × Ovarian Neoplasms × anlotinib × Clear all

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05311579 2022-04-13

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Phase 2 Unknown

36 enrolled

Gynecologic

Ovarian Neoplasms

NCT04566952 2020-10-30

ANLOLA

Phase 2 Unknown

68 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Adnexal Diseases, Carcinoma, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Urogenital Neoplasms

NCT03924882 2019-04-23

Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer

Phase 2 Unknown

30 enrolled

Gynecologic

Ovarian Neoplasms

Clinical Trials

AL3818

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

ANLOLA

Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer